nodes	percent_of_prediction	percent_of_DWPC	metapath
Felodipine—PDE1A—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.0257	0.0257	CbGpPWpGaD
Felodipine—PDE1A—Downstream signal transduction—FRS2—nasal cavity cancer	0.0241	0.0241	CbGpPWpGaD
Felodipine—PDE1A—Signaling by FGFR—FRS2—nasal cavity cancer	0.024	0.024	CbGpPWpGaD
Felodipine—PDE1A—Signaling by ERBB2—FRS2—nasal cavity cancer	0.0239	0.0239	CbGpPWpGaD
Felodipine—PDE1A—DAP12 signaling—FRS2—nasal cavity cancer	0.0238	0.0238	CbGpPWpGaD
Felodipine—PDE1B—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.0235	0.0235	CbGpPWpGaD
Felodipine—PDE1A—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.0224	0.0224	CbGpPWpGaD
Felodipine—PDE1A—DAP12 interactions—FRS2—nasal cavity cancer	0.0224	0.0224	CbGpPWpGaD
Felodipine—PDE1A—Signaling by EGFR—FRS2—nasal cavity cancer	0.0222	0.0222	CbGpPWpGaD
Felodipine—PDE1B—Downstream signal transduction—FRS2—nasal cavity cancer	0.0221	0.0221	CbGpPWpGaD
Felodipine—PDE1A—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.022	0.022	CbGpPWpGaD
Felodipine—PDE1B—Signaling by FGFR—FRS2—nasal cavity cancer	0.022	0.022	CbGpPWpGaD
Felodipine—PDE1A—Signaling by PDGF—FRS2—nasal cavity cancer	0.0219	0.0219	CbGpPWpGaD
Felodipine—PDE1B—Signaling by ERBB2—FRS2—nasal cavity cancer	0.0219	0.0219	CbGpPWpGaD
Felodipine—PDE1B—DAP12 signaling—FRS2—nasal cavity cancer	0.0217	0.0217	CbGpPWpGaD
Felodipine—PDE1B—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.0205	0.0205	CbGpPWpGaD
Felodipine—PDE1B—DAP12 interactions—FRS2—nasal cavity cancer	0.0205	0.0205	CbGpPWpGaD
Felodipine—PDE1B—Signaling by EGFR—FRS2—nasal cavity cancer	0.0203	0.0203	CbGpPWpGaD
Felodipine—PDE1B—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.0201	0.0201	CbGpPWpGaD
Felodipine—PDE1B—Signaling by PDGF—FRS2—nasal cavity cancer	0.02	0.02	CbGpPWpGaD
Felodipine—ABCB1—Allograft Rejection—CXCL11—nasal cavity cancer	0.0199	0.0199	CbGpPWpGaD
Felodipine—PDE1A—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.0198	0.0198	CbGpPWpGaD
Felodipine—PDE1B—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.0181	0.0181	CbGpPWpGaD
Felodipine—PDE1A—Signaling by NGF—FRS2—nasal cavity cancer	0.0152	0.0152	CbGpPWpGaD
Felodipine—PDE1B—Signaling by NGF—FRS2—nasal cavity cancer	0.0139	0.0139	CbGpPWpGaD
Felodipine—PDE1A—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.0104	0.0104	CbGpPWpGaD
Felodipine—PDE1B—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00947	0.00947	CbGpPWpGaD
Felodipine—PDE1A—Signaling by GPCR—CXCL11—nasal cavity cancer	0.0094	0.0094	CbGpPWpGaD
Felodipine—CALM3—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.00931	0.00931	CbGpPWpGaD
Felodipine—CALM2—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.00901	0.00901	CbGpPWpGaD
Felodipine—CALM1—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.00901	0.00901	CbGpPWpGaD
Felodipine—CALM3—Downstream signal transduction—FRS2—nasal cavity cancer	0.00875	0.00875	CbGpPWpGaD
Felodipine—CALM3—Signaling by FGFR—FRS2—nasal cavity cancer	0.00871	0.00871	CbGpPWpGaD
Felodipine—PDE1A—Innate Immune System—FRS2—nasal cavity cancer	0.00869	0.00869	CbGpPWpGaD
Felodipine—CALM3—Signaling by ERBB2—FRS2—nasal cavity cancer	0.00867	0.00867	CbGpPWpGaD
Felodipine—CALM3—DAP12 signaling—FRS2—nasal cavity cancer	0.00862	0.00862	CbGpPWpGaD
Felodipine—PDE1B—Signaling by GPCR—CXCL11—nasal cavity cancer	0.0086	0.0086	CbGpPWpGaD
Felodipine—CALM2—Downstream signal transduction—FRS2—nasal cavity cancer	0.00847	0.00847	CbGpPWpGaD
Felodipine—CALM1—Downstream signal transduction—FRS2—nasal cavity cancer	0.00847	0.00847	CbGpPWpGaD
Felodipine—CALM2—Signaling by FGFR—FRS2—nasal cavity cancer	0.00842	0.00842	CbGpPWpGaD
Felodipine—CALM1—Signaling by FGFR—FRS2—nasal cavity cancer	0.00842	0.00842	CbGpPWpGaD
Felodipine—CALM2—Signaling by ERBB2—FRS2—nasal cavity cancer	0.00838	0.00838	CbGpPWpGaD
Felodipine—CALM1—Signaling by ERBB2—FRS2—nasal cavity cancer	0.00838	0.00838	CbGpPWpGaD
Felodipine—CALM2—DAP12 signaling—FRS2—nasal cavity cancer	0.00834	0.00834	CbGpPWpGaD
Felodipine—CALM1—DAP12 signaling—FRS2—nasal cavity cancer	0.00834	0.00834	CbGpPWpGaD
Felodipine—CALM3—DAP12 interactions—FRS2—nasal cavity cancer	0.00811	0.00811	CbGpPWpGaD
Felodipine—CALM3—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.00811	0.00811	CbGpPWpGaD
Felodipine—CALM3—Fc epsilon receptor (FCERI) signaling—FRS2—nasal cavity cancer	0.00811	0.00811	CbGpPWpGaD
Felodipine—CALM3—Signaling by EGFR—FRS2—nasal cavity cancer	0.00804	0.00804	CbGpPWpGaD
Felodipine—CALM3—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.00797	0.00797	CbGpPWpGaD
Felodipine—PDE1B—Innate Immune System—FRS2—nasal cavity cancer	0.00795	0.00795	CbGpPWpGaD
Felodipine—CALM3—Signaling by PDGF—FRS2—nasal cavity cancer	0.00793	0.00793	CbGpPWpGaD
Felodipine—CALM2—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.00785	0.00785	CbGpPWpGaD
Felodipine—CALM1—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.00785	0.00785	CbGpPWpGaD
Felodipine—CALM2—DAP12 interactions—FRS2—nasal cavity cancer	0.00785	0.00785	CbGpPWpGaD
Felodipine—CALM2—Fc epsilon receptor (FCERI) signaling—FRS2—nasal cavity cancer	0.00785	0.00785	CbGpPWpGaD
Felodipine—CALM1—DAP12 interactions—FRS2—nasal cavity cancer	0.00785	0.00785	CbGpPWpGaD
Felodipine—CALM1—Fc epsilon receptor (FCERI) signaling—FRS2—nasal cavity cancer	0.00785	0.00785	CbGpPWpGaD
Felodipine—CALM1—Signaling by EGFR—FRS2—nasal cavity cancer	0.00778	0.00778	CbGpPWpGaD
Felodipine—CALM2—Signaling by EGFR—FRS2—nasal cavity cancer	0.00778	0.00778	CbGpPWpGaD
Felodipine—CALM1—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.00771	0.00771	CbGpPWpGaD
Felodipine—CALM2—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.00771	0.00771	CbGpPWpGaD
Felodipine—CALM1—Signaling by PDGF—FRS2—nasal cavity cancer	0.00767	0.00767	CbGpPWpGaD
Felodipine—CALM2—Signaling by PDGF—FRS2—nasal cavity cancer	0.00767	0.00767	CbGpPWpGaD
Felodipine—CALM3—B Cell Activation—FRS2—nasal cavity cancer	0.00751	0.00751	CbGpPWpGaD
Felodipine—CALM1—B Cell Activation—FRS2—nasal cavity cancer	0.00726	0.00726	CbGpPWpGaD
Felodipine—CALM2—B Cell Activation—FRS2—nasal cavity cancer	0.00726	0.00726	CbGpPWpGaD
Felodipine—CALM3—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.00719	0.00719	CbGpPWpGaD
Felodipine—CALM2—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.00695	0.00695	CbGpPWpGaD
Felodipine—CALM1—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.00695	0.00695	CbGpPWpGaD
Felodipine—PDE1A—Signaling Pathways—CXCL11—nasal cavity cancer	0.00555	0.00555	CbGpPWpGaD
Felodipine—CALM3—Signaling by NGF—FRS2—nasal cavity cancer	0.00553	0.00553	CbGpPWpGaD
Felodipine—CALM2—Signaling by NGF—FRS2—nasal cavity cancer	0.00535	0.00535	CbGpPWpGaD
Felodipine—CALM1—Signaling by NGF—FRS2—nasal cavity cancer	0.00535	0.00535	CbGpPWpGaD
Felodipine—PDE1B—Signaling Pathways—CXCL11—nasal cavity cancer	0.00508	0.00508	CbGpPWpGaD
Felodipine—PDE1A—Immune System—FRS2—nasal cavity cancer	0.00506	0.00506	CbGpPWpGaD
Felodipine—PDE1A—Disease—FRS2—nasal cavity cancer	0.00467	0.00467	CbGpPWpGaD
Felodipine—PDE1B—Immune System—FRS2—nasal cavity cancer	0.00463	0.00463	CbGpPWpGaD
Felodipine—PDE1B—Disease—FRS2—nasal cavity cancer	0.00428	0.00428	CbGpPWpGaD
Felodipine—CALM3—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00341	0.00341	CbGpPWpGaD
Felodipine—CALM2—Signaling by GPCR—CXCL11—nasal cavity cancer	0.0033	0.0033	CbGpPWpGaD
Felodipine—CALM1—Signaling by GPCR—CXCL11—nasal cavity cancer	0.0033	0.0033	CbGpPWpGaD
Felodipine—PDE1A—Signaling Pathways—FRS2—nasal cavity cancer	0.00327	0.00327	CbGpPWpGaD
Felodipine—CALM3—Innate Immune System—FRS2—nasal cavity cancer	0.00315	0.00315	CbGpPWpGaD
Felodipine—CALM2—Innate Immune System—FRS2—nasal cavity cancer	0.00305	0.00305	CbGpPWpGaD
Felodipine—CALM1—Innate Immune System—FRS2—nasal cavity cancer	0.00305	0.00305	CbGpPWpGaD
Felodipine—CALM3—Adaptive Immune System—FRS2—nasal cavity cancer	0.00303	0.00303	CbGpPWpGaD
Felodipine—PDE1B—Signaling Pathways—FRS2—nasal cavity cancer	0.00299	0.00299	CbGpPWpGaD
Felodipine—CALM1—Adaptive Immune System—FRS2—nasal cavity cancer	0.00293	0.00293	CbGpPWpGaD
Felodipine—CALM2—Adaptive Immune System—FRS2—nasal cavity cancer	0.00293	0.00293	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—CXCL11—nasal cavity cancer	0.00201	0.00201	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—CXCL11—nasal cavity cancer	0.00195	0.00195	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—CXCL11—nasal cavity cancer	0.00195	0.00195	CbGpPWpGaD
Felodipine—CALM3—Immune System—FRS2—nasal cavity cancer	0.00184	0.00184	CbGpPWpGaD
Felodipine—CALM2—Immune System—FRS2—nasal cavity cancer	0.00178	0.00178	CbGpPWpGaD
Felodipine—CALM1—Immune System—FRS2—nasal cavity cancer	0.00178	0.00178	CbGpPWpGaD
Felodipine—CALM3—Disease—FRS2—nasal cavity cancer	0.0017	0.0017	CbGpPWpGaD
Felodipine—CALM2—Disease—FRS2—nasal cavity cancer	0.00164	0.00164	CbGpPWpGaD
Felodipine—CALM1—Disease—FRS2—nasal cavity cancer	0.00164	0.00164	CbGpPWpGaD
Felodipine—CALM3—Signaling Pathways—FRS2—nasal cavity cancer	0.00119	0.00119	CbGpPWpGaD
Felodipine—CALM1—Signaling Pathways—FRS2—nasal cavity cancer	0.00115	0.00115	CbGpPWpGaD
Felodipine—CALM2—Signaling Pathways—FRS2—nasal cavity cancer	0.00115	0.00115	CbGpPWpGaD
